Afrezza 60 4 Un/60 8 Un/60 12 Un (Insulin Regular INHALANT) 60 4 UN/60 8 UN/60 12 UN

AFREZZA 60 4 UN/60 8 UN/60 12 UN is an inhaled insulin used to manage blood sugar in adults with diabetes. This rapid-acting form offers a needle-free alternative to traditional insulin injections. Suitable for those seeking flexible diabetes management options.

Strength

60 4 UN/60 8 UN/60 12 UN

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Mannkind Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AFREZZA is a rapid-acting insulin used to improve glycemic control in adults with diabetes mellitus. It is designed for mealtime insulin needs, helping to lower blood sugar spikes after eating. This inhaled form provides an alternative for patients who prefer not to use injectable insulin. It is not a substitute for long-acting insulin in all cases.

Side Effects

AFREZZA starts working within 12 to 15 minutes after inhalation, peaking around 30 minutes. Effects typically last 2 to 3 hours, helping to manage post-meal blood sugar levels. Users may experience mild throat irritation or cough, which usually resolves over time. Proper inhalation technique ensures consistent absorption.

Precautions & Warnings

Store AFREZZA at 2–8°C (36–46°F) and protect it from light. Once opened, cartridges can be kept at room temperature for up to 10 days. Always check the expiration date before use. Avoid exposing the medication to extreme temperatures or humidity. Keep out of reach of children.

Avoid Interactions

AFREZZA may interact with medications that affect blood sugar levels, such as oral diabetes drugs, beta-blockers, or corticosteroids. Alcohol can increase the risk of hypoglycemia when combined with insulin. Certain drugs, like ACE inhibitors or thyroid hormones, may alter insulin sensitivity. Always inform your healthcare provider about all medications you take.

Frequently Asked Questions

AFREZZA is a rapid-acting insulin used to manage blood sugar levels in adults with diabetes, particularly to control spikes after meals.

Store unopened cartridges refrigerated at 2–8°C (36–46°F). Opened cartridges can be kept at room temperature for up to 10 days.

AFREZZA is not recommended for people with chronic lung conditions like asthma or COPD. Consult your doctor to determine if it’s suitable for you.

AFREZZA begins lowering blood sugar within 12 to 15 minutes after inhalation, with peak effects around 30 minutes.

AFREZZA is a rapid-acting insulin and may not replace long-acting insulin for all patients. Your doctor will determine the best treatment plan.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.